Structure

Physi-Chem Properties

Molecular Weight:  440.37
Volume:  502.881
LogP:  6.279
LogD:  4.989
LogS:  -5.345
# Rotatable Bonds:  5
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.352
Synthetic Accessibility Score:  4.84
Fsp3:  0.833
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.924
MDCK Permeability:  1.1549012015166227e-05
Pgp-inhibitor:  0.348
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.99
30% Bioavailability (F30%):  0.968

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.631
Plasma Protein Binding (PPB):  89.60912322998047%
Volume Distribution (VD):  2.13
Pgp-substrate:  1.9886493682861328%

ADMET: Metabolism

CYP1A2-inhibitor:  0.018
CYP1A2-substrate:  0.462
CYP2C19-inhibitor:  0.12
CYP2C19-substrate:  0.952
CYP2C9-inhibitor:  0.203
CYP2C9-substrate:  0.572
CYP2D6-inhibitor:  0.303
CYP2D6-substrate:  0.424
CYP3A4-inhibitor:  0.695
CYP3A4-substrate:  0.734

ADMET: Excretion

Clearance (CL):  9.681
Half-life (T1/2):  0.038

ADMET: Toxicity

hERG Blockers:  0.038
Human Hepatotoxicity (H-HT):  0.235
Drug-inuced Liver Injury (DILI):  0.019
AMES Toxicity:  0.002
Rat Oral Acute Toxicity:  0.069
Maximum Recommended Daily Dose:  0.926
Skin Sensitization:  0.963
Carcinogencity:  0.035
Eye Corrosion:  0.73
Eye Irritation:  0.692
Respiratory Toxicity:  0.963

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC94755

Natural Product ID:  NPC94755
Common Name*:   3Beta-Hydroxylanosta-8,24-Dien-21-Al
IUPAC Name:   (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enal
Synonyms:  
Standard InCHIKey:  BDXXTCGLJBYHHM-ILLHTMCHSA-N
Standard InCHI:  InChI=1S/C30H48O2/c1-20(2)9-8-10-21(19-31)22-13-17-30(7)24-11-12-25-27(3,4)26(32)15-16-28(25,5)23(24)14-18-29(22,30)6/h9,19,21-22,25-26,32H,8,10-18H2,1-7H3/t21-,22+,25-,26-,28+,29+,30-/m0/s1
SMILES:  O=C[C@@H]([C@H]1CC[C@@]2([C@]1(C)CCC1=C2CC[C@@H]2[C@]1(C)CC[C@@H](C2(C)C)O)C)CCC=C(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL515510
PubChem CID:   44581610
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota sclerotia n.a. n.a. PMID[17049251]
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota sclerotia n.a. n.a. PMID[18387711]
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. PMID[24359303]
NPO18766 Inonotus obliquus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Activity = 70.0 % PMID[568980]
NPT137 Cell Line L1210 Mus musculus IC50 = 34400.0 nM PMID[568981]
NPT2 Others Unspecified Activity = 0.0 % PMID[568980]
NPT2 Others Unspecified Activity = 64.0 % PMID[568980]
NPT2 Others Unspecified Activity = 90.4 % PMID[568980]
NPT32 Organism Mus musculus Mus musculus Activity = 33.3 % PMID[568980]
NPT32 Organism Mus musculus Mus musculus Activity = 1.2 n.a. PMID[568980]
NPT32 Organism Mus musculus Mus musculus Activity = 73.3 % PMID[568980]
NPT32 Organism Mus musculus Mus musculus Activity = 3.8 n.a. PMID[568980]
NPT2 Others Unspecified IC50 = 232.0 molar ratio PMID[568980]
NPT2 Others Unspecified Activity = 35.1 % PMID[568980]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC94755 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9524 High Similarity NPC191684
0.9398 High Similarity NPC159046
0.9398 High Similarity NPC233836
0.9398 High Similarity NPC187376
0.9294 High Similarity NPC183283
0.9286 High Similarity NPC471722
0.9277 High Similarity NPC72133
0.9277 High Similarity NPC55309
0.9277 High Similarity NPC28252
0.9176 High Similarity NPC102414
0.9176 High Similarity NPC77168
0.9176 High Similarity NPC86319
0.9176 High Similarity NPC84271
0.9176 High Similarity NPC275740
0.9167 High Similarity NPC142361
0.9167 High Similarity NPC474684
0.9059 High Similarity NPC143767
0.9059 High Similarity NPC131470
0.9059 High Similarity NPC471724
0.9059 High Similarity NPC242864
0.9036 High Similarity NPC221758
0.9036 High Similarity NPC59453
0.9036 High Similarity NPC473246
0.8953 High Similarity NPC475921
0.8953 High Similarity NPC474704
0.8941 High Similarity NPC475740
0.8941 High Similarity NPC475772
0.8929 High Similarity NPC474083
0.8929 High Similarity NPC470574
0.8875 High Similarity NPC214570
0.8864 High Similarity NPC69454
0.8851 High Similarity NPC111585
0.8851 High Similarity NPC175628
0.8851 High Similarity NPC469400
0.8851 High Similarity NPC148414
0.8837 High Similarity NPC193360
0.8837 High Similarity NPC328539
0.8824 High Similarity NPC475022
0.8824 High Similarity NPC118648
0.8824 High Similarity NPC155011
0.8824 High Similarity NPC31564
0.8824 High Similarity NPC477579
0.8824 High Similarity NPC51014
0.8824 High Similarity NPC474732
0.8824 High Similarity NPC235341
0.8824 High Similarity NPC474733
0.8824 High Similarity NPC474778
0.8824 High Similarity NPC145879
0.8824 High Similarity NPC222613
0.8824 High Similarity NPC95594
0.881 High Similarity NPC74595
0.881 High Similarity NPC264665
0.881 High Similarity NPC85774
0.881 High Similarity NPC214043
0.881 High Similarity NPC82902
0.8795 High Similarity NPC151519
0.8765 High Similarity NPC275910
0.8764 High Similarity NPC292793
0.8764 High Similarity NPC469406
0.875 High Similarity NPC26888
0.875 High Similarity NPC189520
0.875 High Similarity NPC73875
0.875 High Similarity NPC23434
0.875 High Similarity NPC63748
0.875 High Similarity NPC297265
0.875 High Similarity NPC233116
0.875 High Similarity NPC46160
0.875 High Similarity NPC272746
0.875 High Similarity NPC202642
0.8736 High Similarity NPC473999
0.8736 High Similarity NPC32830
0.8736 High Similarity NPC31985
0.8736 High Similarity NPC309603
0.8736 High Similarity NPC474245
0.8736 High Similarity NPC1015
0.8736 High Similarity NPC474889
0.8721 High Similarity NPC138756
0.8721 High Similarity NPC58063
0.8706 High Similarity NPC471224
0.8706 High Similarity NPC474218
0.869 High Similarity NPC278648
0.869 High Similarity NPC476082
0.8667 High Similarity NPC162001
0.8667 High Similarity NPC259286
0.8667 High Similarity NPC45324
0.8667 High Similarity NPC222845
0.8652 High Similarity NPC250575
0.8652 High Similarity NPC470376
0.8652 High Similarity NPC470224
0.8652 High Similarity NPC475255
0.8652 High Similarity NPC470375
0.8636 High Similarity NPC48010
0.8636 High Similarity NPC471896
0.8636 High Similarity NPC126993
0.8636 High Similarity NPC85173
0.8625 High Similarity NPC322353
0.8625 High Similarity NPC121744
0.8625 High Similarity NPC118508
0.8621 High Similarity NPC53911
0.8621 High Similarity NPC328313
0.8621 High Similarity NPC206060
0.8605 High Similarity NPC89077
0.8605 High Similarity NPC269396
0.8605 High Similarity NPC98236
0.8605 High Similarity NPC469994
0.8588 High Similarity NPC165064
0.8571 High Similarity NPC78473
0.8571 High Similarity NPC48362
0.8571 High Similarity NPC192428
0.8571 High Similarity NPC173272
0.8571 High Similarity NPC249954
0.8556 High Similarity NPC166906
0.8556 High Similarity NPC196485
0.8556 High Similarity NPC245972
0.8556 High Similarity NPC111015
0.8539 High Similarity NPC475806
0.8539 High Similarity NPC473998
0.8539 High Similarity NPC185936
0.8539 High Similarity NPC86266
0.8539 High Similarity NPC212301
0.8539 High Similarity NPC110657
0.8539 High Similarity NPC168027
0.8537 High Similarity NPC205455
0.8537 High Similarity NPC186191
0.8523 High Similarity NPC472970
0.8523 High Similarity NPC186688
0.8523 High Similarity NPC119416
0.8523 High Similarity NPC472971
0.8523 High Similarity NPC76879
0.8523 High Similarity NPC26959
0.8523 High Similarity NPC128496
0.8523 High Similarity NPC268406
0.8519 High Similarity NPC470362
0.8519 High Similarity NPC189883
0.8506 High Similarity NPC90652
0.8506 High Similarity NPC317590
0.8506 High Similarity NPC89747
0.8506 High Similarity NPC141292
0.8506 High Similarity NPC136548
0.8488 Intermediate Similarity NPC469948
0.8488 Intermediate Similarity NPC133954
0.8488 Intermediate Similarity NPC202868
0.8478 Intermediate Similarity NPC126815
0.8478 Intermediate Similarity NPC291634
0.8471 Intermediate Similarity NPC475726
0.8471 Intermediate Similarity NPC472743
0.8462 Intermediate Similarity NPC470016
0.8462 Intermediate Similarity NPC127063
0.8462 Intermediate Similarity NPC271195
0.8462 Intermediate Similarity NPC317586
0.8462 Intermediate Similarity NPC69548
0.8462 Intermediate Similarity NPC184848
0.8462 Intermediate Similarity NPC48330
0.8452 Intermediate Similarity NPC38350
0.8452 Intermediate Similarity NPC201912
0.8452 Intermediate Similarity NPC473420
0.8444 Intermediate Similarity NPC170220
0.8444 Intermediate Similarity NPC472930
0.8444 Intermediate Similarity NPC12722
0.8444 Intermediate Similarity NPC134826
0.8444 Intermediate Similarity NPC107674
0.8444 Intermediate Similarity NPC141497
0.8444 Intermediate Similarity NPC477855
0.8434 Intermediate Similarity NPC1319
0.8434 Intermediate Similarity NPC472490
0.8427 Intermediate Similarity NPC69622
0.8427 Intermediate Similarity NPC20388
0.8427 Intermediate Similarity NPC136801
0.8409 Intermediate Similarity NPC474925
0.8409 Intermediate Similarity NPC472739
0.8409 Intermediate Similarity NPC310752
0.8409 Intermediate Similarity NPC44181
0.8409 Intermediate Similarity NPC292491
0.8409 Intermediate Similarity NPC470417
0.8395 Intermediate Similarity NPC471723
0.8395 Intermediate Similarity NPC141071
0.8395 Intermediate Similarity NPC257347
0.8391 Intermediate Similarity NPC475862
0.8391 Intermediate Similarity NPC473168
0.8391 Intermediate Similarity NPC20688
0.8391 Intermediate Similarity NPC325594
0.8391 Intermediate Similarity NPC73038
0.8391 Intermediate Similarity NPC74363
0.8391 Intermediate Similarity NPC213412
0.8387 Intermediate Similarity NPC477813
0.8387 Intermediate Similarity NPC186810
0.8387 Intermediate Similarity NPC48647
0.8375 Intermediate Similarity NPC201373
0.8372 Intermediate Similarity NPC474482
0.8372 Intermediate Similarity NPC329043
0.8372 Intermediate Similarity NPC237712
0.8372 Intermediate Similarity NPC161423
0.8372 Intermediate Similarity NPC227064
0.8372 Intermediate Similarity NPC321187
0.8372 Intermediate Similarity NPC475745
0.8372 Intermediate Similarity NPC472265
0.8372 Intermediate Similarity NPC58841
0.837 Intermediate Similarity NPC120708
0.837 Intermediate Similarity NPC305483
0.837 Intermediate Similarity NPC328162

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC94755 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9036 High Similarity NPD4786 Approved
0.8953 High Similarity NPD5328 Approved
0.8824 High Similarity NPD3618 Phase 1
0.8795 High Similarity NPD3667 Approved
0.875 High Similarity NPD6079 Approved
0.8571 High Similarity NPD4697 Phase 3
0.8444 Intermediate Similarity NPD4202 Approved
0.8391 Intermediate Similarity NPD5279 Phase 3
0.8372 Intermediate Similarity NPD3666 Approved
0.8372 Intermediate Similarity NPD3133 Approved
0.8372 Intermediate Similarity NPD3665 Phase 1
0.8276 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8172 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8172 Intermediate Similarity NPD5222 Approved
0.8172 Intermediate Similarity NPD5221 Approved
0.8171 Intermediate Similarity NPD7339 Approved
0.8171 Intermediate Similarity NPD6942 Approved
0.8118 Intermediate Similarity NPD7525 Registered
0.8085 Intermediate Similarity NPD5173 Approved
0.8085 Intermediate Similarity NPD4755 Approved
0.8043 Intermediate Similarity NPD6399 Phase 3
0.7955 Intermediate Similarity NPD3668 Phase 3
0.7935 Intermediate Similarity NPD7515 Phase 2
0.7931 Intermediate Similarity NPD4221 Approved
0.7931 Intermediate Similarity NPD4223 Phase 3
0.7917 Intermediate Similarity NPD5286 Approved
0.7917 Intermediate Similarity NPD4700 Approved
0.7917 Intermediate Similarity NPD4696 Approved
0.7917 Intermediate Similarity NPD5285 Approved
0.7912 Intermediate Similarity NPD4753 Phase 2
0.7865 Intermediate Similarity NPD5329 Approved
0.7857 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7835 Intermediate Similarity NPD5223 Approved
0.7778 Intermediate Similarity NPD5280 Approved
0.7778 Intermediate Similarity NPD5690 Phase 2
0.7778 Intermediate Similarity NPD4694 Approved
0.7755 Intermediate Similarity NPD5224 Approved
0.7755 Intermediate Similarity NPD5211 Phase 2
0.7755 Intermediate Similarity NPD5225 Approved
0.7755 Intermediate Similarity NPD5226 Approved
0.7755 Intermediate Similarity NPD4633 Approved
0.7753 Intermediate Similarity NPD4197 Approved
0.77 Intermediate Similarity NPD5739 Approved
0.77 Intermediate Similarity NPD7128 Approved
0.77 Intermediate Similarity NPD6675 Approved
0.77 Intermediate Similarity NPD6402 Approved
0.7677 Intermediate Similarity NPD4754 Approved
0.7677 Intermediate Similarity NPD5174 Approved
0.7677 Intermediate Similarity NPD5175 Approved
0.764 Intermediate Similarity NPD4788 Approved
0.7614 Intermediate Similarity NPD4692 Approved
0.7614 Intermediate Similarity NPD4139 Approved
0.76 Intermediate Similarity NPD5141 Approved
0.759 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD7645 Phase 2
0.7582 Intermediate Similarity NPD5330 Approved
0.7582 Intermediate Similarity NPD6409 Approved
0.7582 Intermediate Similarity NPD4689 Approved
0.7582 Intermediate Similarity NPD6684 Approved
0.7582 Intermediate Similarity NPD5205 Approved
0.7582 Intermediate Similarity NPD7521 Approved
0.7582 Intermediate Similarity NPD7334 Approved
0.7582 Intermediate Similarity NPD4693 Phase 3
0.7582 Intermediate Similarity NPD4690 Approved
0.7582 Intermediate Similarity NPD4138 Approved
0.7582 Intermediate Similarity NPD7146 Approved
0.7582 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD4688 Approved
0.7579 Intermediate Similarity NPD7748 Approved
0.7553 Intermediate Similarity NPD8035 Phase 2
0.7553 Intermediate Similarity NPD8034 Phase 2
0.7549 Intermediate Similarity NPD6899 Approved
0.7549 Intermediate Similarity NPD6881 Approved
0.7549 Intermediate Similarity NPD7320 Approved
0.7526 Intermediate Similarity NPD6084 Phase 2
0.7526 Intermediate Similarity NPD6083 Phase 2
0.7525 Intermediate Similarity NPD4767 Approved
0.7525 Intermediate Similarity NPD4768 Approved
0.75 Intermediate Similarity NPD4629 Approved
0.75 Intermediate Similarity NPD4748 Discontinued
0.75 Intermediate Similarity NPD5695 Phase 3
0.75 Intermediate Similarity NPD5210 Approved
0.7476 Intermediate Similarity NPD6373 Approved
0.7476 Intermediate Similarity NPD6372 Approved
0.7471 Intermediate Similarity NPD3617 Approved
0.7451 Intermediate Similarity NPD5697 Approved
0.7451 Intermediate Similarity NPD5701 Approved
0.7449 Intermediate Similarity NPD7638 Approved
0.7442 Intermediate Similarity NPD6117 Approved
0.7419 Intermediate Similarity NPD6672 Approved
0.7419 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD6903 Approved
0.7419 Intermediate Similarity NPD5737 Approved
0.7412 Intermediate Similarity NPD6926 Approved
0.7412 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD5733 Approved
0.7412 Intermediate Similarity NPD6924 Approved
0.7404 Intermediate Similarity NPD7290 Approved
0.7404 Intermediate Similarity NPD6883 Approved
0.7404 Intermediate Similarity NPD7102 Approved
0.7381 Intermediate Similarity NPD4243 Approved
0.7379 Intermediate Similarity NPD6011 Approved
0.7379 Intermediate Similarity NPD5168 Approved
0.7379 Intermediate Similarity NPD4729 Approved
0.7379 Intermediate Similarity NPD5128 Approved
0.7379 Intermediate Similarity NPD4730 Approved
0.7374 Intermediate Similarity NPD7639 Approved
0.7374 Intermediate Similarity NPD7640 Approved
0.7368 Intermediate Similarity NPD5284 Approved
0.7368 Intermediate Similarity NPD5281 Approved
0.7356 Intermediate Similarity NPD6116 Phase 1
0.7349 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD7902 Approved
0.7333 Intermediate Similarity NPD6869 Approved
0.7333 Intermediate Similarity NPD8130 Phase 1
0.7333 Intermediate Similarity NPD6617 Approved
0.7333 Intermediate Similarity NPD6649 Approved
0.7333 Intermediate Similarity NPD6847 Approved
0.7333 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6650 Approved
0.7308 Intermediate Similarity NPD6012 Approved
0.7308 Intermediate Similarity NPD6014 Approved
0.7308 Intermediate Similarity NPD6013 Approved
0.7273 Intermediate Similarity NPD6114 Approved
0.7273 Intermediate Similarity NPD6697 Approved
0.7273 Intermediate Similarity NPD6118 Approved
0.7273 Intermediate Similarity NPD6115 Approved
0.7264 Intermediate Similarity NPD6882 Approved
0.7264 Intermediate Similarity NPD8297 Approved
0.7263 Intermediate Similarity NPD4096 Approved
0.7262 Intermediate Similarity NPD4747 Approved
0.7241 Intermediate Similarity NPD6933 Approved
0.7238 Intermediate Similarity NPD5135 Approved
0.7238 Intermediate Similarity NPD5250 Approved
0.7238 Intermediate Similarity NPD5251 Approved
0.7238 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD5169 Approved
0.7238 Intermediate Similarity NPD4634 Approved
0.7238 Intermediate Similarity NPD5247 Approved
0.7238 Intermediate Similarity NPD5249 Phase 3
0.7238 Intermediate Similarity NPD5248 Approved
0.7209 Intermediate Similarity NPD4687 Approved
0.7209 Intermediate Similarity NPD4784 Approved
0.7209 Intermediate Similarity NPD4785 Approved
0.7204 Intermediate Similarity NPD6098 Approved
0.7191 Intermediate Similarity NPD4195 Approved
0.7188 Intermediate Similarity NPD6411 Approved
0.7176 Intermediate Similarity NPD7151 Approved
0.7176 Intermediate Similarity NPD7150 Approved
0.7176 Intermediate Similarity NPD5276 Approved
0.7176 Intermediate Similarity NPD7152 Approved
0.717 Intermediate Similarity NPD5217 Approved
0.717 Intermediate Similarity NPD5216 Approved
0.717 Intermediate Similarity NPD5127 Approved
0.717 Intermediate Similarity NPD5215 Approved
0.7143 Intermediate Similarity NPD4137 Phase 3
0.7143 Intermediate Similarity NPD6923 Approved
0.7143 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6922 Approved
0.7128 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD3703 Phase 2
0.7113 Intermediate Similarity NPD5133 Approved
0.7111 Intermediate Similarity NPD4695 Discontinued
0.71 Intermediate Similarity NPD5696 Approved
0.7079 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7064 Intermediate Similarity NPD6868 Approved
0.7059 Intermediate Similarity NPD4244 Approved
0.7059 Intermediate Similarity NPD7144 Approved
0.7059 Intermediate Similarity NPD4789 Approved
0.7059 Intermediate Similarity NPD7143 Approved
0.7059 Intermediate Similarity NPD4245 Approved
0.7059 Intermediate Similarity NPD4691 Approved
0.7053 Intermediate Similarity NPD4518 Approved
0.7041 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD7900 Approved
0.7037 Intermediate Similarity NPD4632 Approved
0.7024 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD5360 Phase 3
0.7021 Intermediate Similarity NPD4519 Discontinued
0.7021 Intermediate Similarity NPD4623 Approved
0.701 Intermediate Similarity NPD6050 Approved
0.7 Intermediate Similarity NPD7115 Discovery
0.7 Intermediate Similarity NPD6929 Approved
0.6979 Remote Similarity NPD6904 Approved
0.6979 Remote Similarity NPD6673 Approved
0.6979 Remote Similarity NPD6080 Approved
0.6979 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6979 Remote Similarity NPD6101 Approved
0.6972 Remote Similarity NPD5167 Approved
0.6952 Remote Similarity NPD6412 Phase 2
0.6941 Remote Similarity NPD3698 Phase 2
0.6937 Remote Similarity NPD6335 Approved
0.6932 Remote Similarity NPD5275 Approved
0.6932 Remote Similarity NPD4190 Phase 3
0.6932 Remote Similarity NPD8264 Approved
0.6931 Remote Similarity NPD5290 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data